“…Interestingly, adiponectin and omentin-1 share the same pattern of physiological effects i.e. both are downregulated in obesity [3,28], both have been proposed to have a beneficial effect on glucose metabolism and insulin sensitivity [1,29], and both were discussed as cardio-protective adipokines [28,30]. However, the association between omentin-1 and stroke risk was particularly strong among individuals with high adiponectin levels compared to those with low levels.…”